Skip to main content

Advertisement

SpringerLink
Log in

Totally antibiotic resistance Pseudomonas aeruginosa isolated from patients with blood stream infection

  • Original Article
  • Published:
Applied Nanoscience Aims and scope Submit manuscript

Abstract

Pathogenic bacteria are the type of bacteria that is harmful to humans and can cause several diseases such as lung diseases, cholera, tuberculosis and syphilis. The multidrug-resistant bacteria that isolated from the patients were Klebsiella spp., Escherichia coli, Pseudomonas aeruginosa, that are known as the human pathogenic bacteria. The antibiotics that have been used against these bacteria were Meropenem MEM, Imipenem IPM, Gentamicin GNT, Co-AmoxiclavAMC and Ceftriaxone CRO. For the vial antibiotics, two different concentrations were prepared and Mueller Hinton agar used as the culture media. Pseudomonas aeruginosa was resistant against all vial and disk antibiotics. Escherichia coli was susceptible against all vial drugs and disks except ceftriaxone 10 mcg. Klebsiella spp. was susceptible against all vial and disk antibiotics. However, it was resistant against Ceftriaxone 10 mcg disk and Gentamicin 10 mcg. The most effective drug against all bacteria was Meropenem vial and disk. The most resistant bacteria against all antibiotic disks was Pseudomonas aeruginosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  • Abd El-Baky RM, Masoud SM, Mohamed DS, Waly NG, Shafik EA, Mohareb DA, Elkady A, El-Badr MM, Hetta HF (2020) Prevalence and some possible mechanisms of colistin resistance among multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa. Infect Drug Resist 13:323

    Article  Google Scholar 

  • Carpenter JL (1990) Klebsiella pulmonary infections: occurrence at one medical center and review. Rev Infect Dis 12(4):672–682

    Article  CAS  Google Scholar 

  • Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Hill AT (2014) The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med 189(5):576–585

    Article  Google Scholar 

  • Erb A, Stürmer T, Marre R, Brenner H (2007) Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis 26(2):83–90

    Article  CAS  Google Scholar 

  • Griffith DC, Sabet M, Tarazi Z, Lomovskaya O, Dudley MN (2019) Pharmacokinetics/pharmacodynamics of vaborbactam, a novel beta-lactamase inhibitor, in combination with meropenem. Antimicrob Agents Chemother. https://doi.org/10.1128/AAC.01659-18

    Article  Google Scholar 

  • Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S (2019) Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev. https://doi.org/10.1128/CMR.00031-19

    Article  Google Scholar 

  • Hussein AM, Taha ZB, Malek AG, Rasul KA, Hazim DQ, Ahmed RJ, Mohamed UB (2021) D-dimer and serum ferritin as an independent risk factor for severity in COVID-19 patients. Materials Today: Proceedings.

  • Jahangiri A, Neshani A, Mirhosseini SA, Ghazvini K, Zare H, Sedighian H (2021) Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates. Microb Pathog 150:104700

    Article  CAS  Google Scholar 

  • Johnson TJ, Logue CM, Johnson JR, Kuskowski MA, Sherwood JS, Barnes HJ, Nolan LK (2012) Associations between multidrug resistance, plasmid content, and virulence potential among extraintestinal pathogenic and commensal Escherichia coli from humans and poultry. Foodborne Pathog Dis 9(1):37–46

    Article  CAS  Google Scholar 

  • Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2(2):123–140

    Article  CAS  Google Scholar 

  • Liao S, Zhang Y, Pan X, Zhu F, Jiang C, Liu Q, Cheng Z, Dai G, Wu G, Wang L, Chen L (2019) Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa. Int J Nanomed 14:1469

    Article  CAS  Google Scholar 

  • Lin JL, Xu JF, Qu JM (2016) Bronchiectasis in China. Ann Am Thorac Soc 13(5):609–616

    Article  Google Scholar 

  • Loebinger MR, Wells AU, Hansell DM, Chinyanganya N, Devaraj A, Meister M, Wilson R (2009) Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 34(4):843–849

    Article  CAS  Google Scholar 

  • Long SS, Prober CG, Fischer M (2017) Principles and practice of pediatric infectious diseases E-book. Elsevier, Amsterdam

    Google Scholar 

  • Martínez-García MÁ, De Gracia J, Relat MV, Girón RM, Carro LM, de la Rosa Carrillo D, Olveira C (2014) Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J 43(5):1357–1367

    Article  Google Scholar 

  • Odabaş-Serin Z, Hussein AM, Taha ZB (2020) Effect of Isatis spp. extraction on the growth of Aspergillus niger and Candida albicans. Cihan Univ Erbil Sci J 4(1):85–99

    Article  Google Scholar 

  • Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11(4):589–603

    Article  CAS  Google Scholar 

  • Pogue JM, Kaye KS, Veve MP, Patel TS, Gerlach AT, Davis SL, Puzniak LA, File TM, Olson S, Dhar S, Bonomo RA (2020) Ceftolozane/tazobactam vs polymyxin or aminoglycoside-based regimens for the treatment of drug-resistant Pseudomonas aeruginosa. Clin Infect Dis 71(2):304–310

    Article  CAS  Google Scholar 

  • Rossolini GM, Stone GG (2020) Assessment of the in vitro activity of ceftazidime/avibactam against a global collection of multidrug-resistant Klebsiella spp. from the INFORM surveillance programme (2015–2017). Int J Antimicrob Agents 56(3):106111

    Article  CAS  Google Scholar 

  • Saleem H, Malik SH (2019) Life threatening anaphylaxis with co-amoxiclav despite having a previous tolerant exposure to the antibiotic. J Ayub Med Coll Abbottabad JAMC 31(4):S680–S682

    Google Scholar 

  • Steil D, Pohlentz G, Legros N, Mormann M, Mellmann A, Karch H, Müthing J (2018) Combining mass spectrometry, surface acoustic wave interaction analysis, and cell viability assays for characterization of Shiga toxin subtypes of pathogenic Escherichia coli bacteria. Anal Chem 90(15):8989–8997

    Article  CAS  Google Scholar 

  • Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Elborn JS (2013) Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med 187(10):1118–1126

    Article  Google Scholar 

  • Von Baum H, Marre R (2005) Antimicrobial resistance of Escherichia coli and therapeutic implications. Int J Med Microbiol 295(6–7):503–511

    Article  Google Scholar 

  • Wang H, Ji XB, Mao B, Li CW, Lu HW, Xu JF (2018) Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study. BMJ Open 8(3):e014613

    Article  Google Scholar 

  • Winstanley C, O’Brien S, Brockhurst MA (2016) Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol 24(5):327–337

    Article  CAS  Google Scholar 

  • World Health Organization (2012) The evolving threat of antimicrobial resistance: options for action. World Health Organization, Geneva

    Google Scholar 

Download references

Acknowledgements

We would like to express our appreciation to Cihan University-Erbil for giving us the opportunity to do our research in the laboratory and fund the research and many thanks for Kalar Hospital for isolating the pathogens.

Funding

This study was self-funded.

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences, Cihan University-Erbil, Erbil, Kurdistan Region, Iraq

    Ali M. Hussein

  2. Department of Forestry, College of Agricultural Engineering Sciences, Salahaddin University, Erbil, Kurdistan, Iraq

    Zhala B. Taha

  3. Department of Biology, Cihan University, Erbil, Kurdistan Region, Iraq

    Ahmed G. Malik, Dur K. Hazim, Reman J. Ahmed, Osama B. Mohammed & Kamgar A. Rasul

  4. Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Karolinska University Hospital Huddinge, 141 86, Huddinge, Sweden

    Safa Bazaz & Dosti Rashid

Authors
  1. Ali M. Hussein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhala B. Taha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed G. Malik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dur K. Hazim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Reman J. Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Osama B. Mohammed
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kamgar A. Rasul
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Safa Bazaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dosti Rashid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali M. Hussein.

Ethics declarations

Conflict of interest

All authors declare, have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hussein, A.M., Taha, Z.B., Malik, A.G. et al. Totally antibiotic resistance Pseudomonas aeruginosa isolated from patients with blood stream infection. Appl Nanosci 13, 1561–1568 (2023). https://doi.org/10.1007/s13204-021-02050-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13204-021-02050-9

Keywords

Search

Navigation